ArticleGlycoprotein IIb/IIIa inhibitors in acute coronary syndromesAuthor:Shelly K. Sapp, MSPublish date: February 1, 2000These potent antiplatelet agents constitute a breakthrough, but questions remain about their safety, cost-effectiveness, and proper empiric use. Wi...Read More
